SCHEMBL2106696

SCHEMBL2106696

CC12CCCCC1C(=O)NC2=O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP19A1 P11511 5/20 0.31
HSD11B1 P28845 2/20 0.31
AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6299278 0.76
SCHEMBL476025 0.72 LMNA (0.34) CCR2HTTHSD11B1
SCHEMBL5031774 0.72 LMNA (0.34) CCR2HTTHSD11B1
SCHEMBL2011171 0.72 HSD11B1 (0.31) HSD11B1
SCHEMBL6901500 0.72 HSD11B1 (0.31) HSD11B1
SCHEMBL17583481 0.72 HSD11B1 (0.33) CCR2HTTHSD11B1
SCHEMBL11403210 0.72 HTT (0.30) HTT
Hydrochloric Acid SCHEMBL5234106 0.71 LMNA (0.33) HTTHSD11B1
SCHEMBL3862997 0.69 MAPK1 (0.39) CCR2HTTKDM4E
SCHEMBL1533789 0.69 HSD11B1 (0.33) HTTCYP19A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP claimed
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US claimed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP claimed
EP-0885214-A1 CYCLIC IMIDO-1,3,5-TRIAZINE CROSSLINKING AGENTS Cytec Technology Corp. (US) 1998-12-23 EP claimed
WO-1997031914-A1 CYCLIC IMIDO-1,3,5-TRIAZINE CROSSLINKING AGENTS CYTEC TECHNOLOGY CORP. (US) 1997-09-04 WO claimed
US-5006621-A Co-polymers of long chain alkyl acrylates with N-containing olefins and their use as flow improvers for crude oils HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1991-04-09 US claimed
EP-0334155-A1 Copolymers of long-chain alkyl acrylates with n-containing olefins, process for their preparation and their use as flow improvers in crude oils Henkel Kommanditgesellschaft auf Aktien (DE) 1989-09-27 EP claimed
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP disclosed
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US disclosed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP disclosed
EP-2651875-B1 AMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECH AG (CH) 2017-08-30 EP disclosed
US-9290603-B2 Amines having secondary aliphatic amino groups SIKA TECHNOLOGY AG (CH) 2016-03-22 US disclosed
EP-2651875-A1 AMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS Sika Technology AG (CH) 2013-10-23 EP disclosed
EP-2194082-B1 Aldimine and composition comprising aldimine SIKA TECHNOLOGY AG (CH) 2011-09-07 EP disclosed
WO-2010063741-A1 ALDIMINE AND COMPOSITION CONTAINING ALDIMINE SIKA TECHNOLOGY AG (CH) 2010-06-10 WO disclosed
EP-2194082-A1 Aldimine and composition comprising aldimine Sika Technology AG (CH) 2010-06-09 EP disclosed
EP-0355676-B1 USE OF COPOLYMERS OF HIGHER ALKYL ACRYLATES WITH N-CONTAINING OLEFINS AS LEVELLING AGENTS FOR POWDER COATINGS Henkel Kommanditgesellschaft auf Aktien (DE) 1993-04-28 EP disclosed
US-5047259-A For powder coating; long chain alkyl acrylates; solventless paint systems HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1991-09-10 US disclosed
EP-0355676-A2 Use of copolymers of higher alkyl acrylates with N-containing olefins as levelling agents for powder coatings Henkel Kommanditgesellschaft auf Aktien (DE) 1990-02-28 EP disclosed
EP-0334155-A1 Copolymers of long-chain alkyl acrylates with n-containing olefins, process for their preparation and their use as flow improvers in crude oils Henkel Kommanditgesellschaft auf Aktien (DE) 1989-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND DPYD, RPLP2, DHPS CCR2 1975/4885HTT 3313/4885KDM4E 1847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.